Leading Transformation
As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Under her leadership, the company is reshaping its go-to-market strategies and recalibrating its asset footprint – all while fostering a dynamic workplace culture amid industry challenges. In this interview with Christene Smith of CHEManager, Gerber shares insights on balancing short-term profitability with long-term green investments, scaling sustainable technologies worldwide, and cultivating an agile organization ready for the future of chemicals. This conversation offers a compelling glimpse into the strategic vision and leadership fueling Sasol’s transformation journey.
CHEManager: Since your appointment as EVP, what has shaped your overarching strategic vision for building resilience and long-term value in Sasol’s international chemicals business?
Antje Gerber: Coming from outside the company, I knew Sasol had a fantastic reputation in the market. And once I began working and got to know the company from the inside, I saw first-hand our strengths – a highly capable workforce, excellent customer relationships, robust research and development, great products, and some tremendous assets.
But I also saw that we were underperforming our peers, even though we were all facing the same challenging global chemicals market.
To change the company’s trajectory, I recognized that we must move away from the fragmented, siloed structure that had developed over time and become a global, collaborative organization – removing the regional mindset from our business and replacing it with an “all for one” approach, both in how we work and how we view our progress and results.
From there, a three-pronged strategy was developed to build long-term value.
First, adopt a new go-to-market approach, one that uses different models for commodities and specialties and focuses on value over volume. We are “leaning in” to the markets and products where we have an advantage and working to strengthen our offerings and our presence. In the past we tried to be everything to everyone, but we cannot afford that approach. So, we have begun a disciplined segmentation approach to our portfolio that is leading to more value-focused technical engagements.
Second, optimize our asset base, close or mothball underperforming assets – including non-core facilities in the US, Germany and Italy. That was a difficult but necessary step to improve our long-term financial performance.
And finally, work diligently – and successfully – to reduce our cost structure. We have a leaner executive team; we’ve consolidated functions along the global value chain; and we’re standardizing systems and implementing best practices globally. Today, we are more efficient and we make decisions more quickly.
What unique strategies have you introduced to cultivate a resilient and agile workplace culture — enabling innovation while navigating significant organizational changes as EVP of International Chemicals?
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
SasolSasol Place, 50 Katherine Street
2196 Sandton
South Africa
most read

Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

Ratcliffe: Chemical Industry in Europe at a Tipping Point
Ineos CEO Ineos calls on European politicians to save the chemical industry.

Novo Nordisk to Cut 9,000 Jobs Globally in Major Restructuring
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.

Merck Acquires Chromatography Business from JSR Life Sciences
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.

BASF Sells Majority Stake in Coatings Business
BASF sells a majority stake in its coatings business to the investor Carlyle.












